Phacet provides an open‑source, searchable knowledge base (Phacet.info) that aggregates dosing studies for obese and post‑bariatric patients, accessible to clinicians via professional‑email login. It also offers the Phacet Compound Server, a GAMP‑compliant platform that receives electronic compounding orders, validates feasibility, and returns preparation proposals through REST APIs and a Windows client for integration with e‑prescribing systems and robotic compounding equipment.
Funding
$4.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinicians treating patients with obesity or post‑bariatric surgery often lack a consolidated, up‑to‑date source of drug‑dosing information, forcing them to rely on scattered studies. Additionally, pharmacies face fragmented workflows when translating electronic prescriptions into compounded preparations, leading to delays and potential errors.
Solution
Phacet delivers a two‑pronged digital platform to address these gaps. Phacet.info is an open‑source, searchable knowledge base that aggregates abstracts and open‑access publications on drug dosing for obese and post‑bariatric patients, organized by disorder and generic drug class. Healthcare professionals can obtain free access via a professional‑email login and receive regular webinars on navigating the repository. Complementing the knowledge base, the Phacet Compound Server provides an open‑source, GAMP‑compliant server that ingests compounding orders from electronic prescribing systems, evaluates feasibility against pharmaceutical constraints and scheduling, and returns a negotiated preparation proposal. The server exposes APIs for integration with existing e‑prescribing tools and robotic compounding equipment, and includes a Windows desktop selector for end‑user access. Both components are released under the GNU GPL, enabling institutions to host, customize, and extend the software while maintaining auditability and trust.
Target Audience
Primary users are physicians, pharmacists, and clinical pharmacologists who manage medication regimens for obese or post‑bariatric patients, as well as pharmacy departments and health‑system IT teams seeking an open‑source compounding workflow solution.
Features
- Curated, searchable database of dosing studies for obesity and bariatric surgery, indexed by disorder and generic drug class
- Free professional‑email subscription workflow with secure login and no tracking or cookies
- Regular live webinars and HELP documentation to accelerate knowledge retrieval
- Open‑source Compound Server that accepts electronic compounding orders, validates against pharmaceutical and scheduling constraints, and returns modifiable proposals
- RESTful API and robot‑interface layer for seamless integration with e‑prescribing platforms and automated compounding hardware
- GAMP‑aligned architecture that isolates business logic for compliance and auditability
- Windows desktop selector client for secure access to institution‑hosted Phacet.info or Compound Server instances
- Fully GPL‑licensed source code with versioned releases downloadable for on‑premises deployment